Search Results
Jan 12, 2026, 12:00 ET ColorTokens Achieves FedRAMP® Moderate Authorization, Accelerating Secure Zero Trust Adoption Across Federal Agencies
unified visibility across diverse federal IT and operational ecosystems, reducing operational overhead while supporting compliance with NIST 800-53 Rev. 5 controls and federal cybersecurity directives.ColorTokens further differentiates by delivering a single microsegmentation platform that spans
More news about: ColorTokens
Jan 12, 2026, 11:00 ET UNIVERSITY OF DETROIT JESUIT HIGH SCHOOL AND ACADEMY NAMES 2006 GRADUATE, FR. DANIEL DIXON, S.J., AS 31ST PRESIDENT
Fr. Dan Dixon '06, S.J., as the next President of the University of Detroit Jesuit High School and Academy offers me deep consolation," said the Very Rev. Karl J. Kiser, S.J., Provincial of the Midwest Jesuits. "I enjoyed the distinct blessing of leading U of D Jesuit for 14 years, so the school is near
More news about: University of Detroit Jesuit
Jan 10, 2026, 10:00 ET RYBREVANT® (amivantamab-vmjw) longer-term results show promising and durable responses in difficult-to-treat colorectal cancer
doi:10.1016/j.jcmgh.2023.08.0125 Grothey A, Lenz HJ. Exploring new treatments for advanced colorectal cancer: current standards and future directions. Cancer Treat Rev. 2020;86:102017. doi:10.1016/j.ctrv.2020.1020176 Kumar A, Gautam V, et al. Current and emerging therapeutic approaches for colorectal
More news about: Johnson & Johnson
Jan 09, 2026, 09:43 ET Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly
SmPC Oczyesa®Colao A., et al. Acromegaly. Nat Rev Dis Primers. 2019;5(1):20.Webb SM, et al. Quality of Life in Acromegaly. Neuroendocrinology. 2016;103(1):106-111.Fleseriu
More news about: Camurus AB
Jan 09, 2026, 09:36 ET Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly
SmPC Oczyesa®Colao A., et al. Acromegaly. Nat Rev Dis Primers. 2019;5(1):20.Webb SM, et al. Quality of Life in Acromegaly. Neuroendocrinology. 2016;103(1):106-111.Fleseriu
More news about: Camurus AB
Jan 08, 2026, 12:49 ET Halper Sadeh LLC Encourages THS, FOLD, REVG Shareholders to Contact the Firm to Discuss Their Rights
more about your legal rights and options.REV Group, Inc. (NYSE: REVG)'s sale to Terex Corporation for 0.9809 of a share of the combined company and $8.71 in cash for each REV Group share. If you are a REV Group shareholder,
More news about: Halper Sadeh LLP
Jan 08, 2026, 11:51 ET Halper Sadeh LLC Encourages HOLX, VTYX, QRVO, TEX Shareholders to Contact the Firm to Discuss Their Rights
click here to learn more about your rights and options.Terex Corporation (NYSE: TEX)'s merger with REV Group. Upon completion of the proposed transaction, Terex shareholders will own approximately 58% of the combined company. If you are a Terex shareholder,
More news about: Halper Sadeh LLP
Jan 08, 2026, 11:39 ET Bionova Scientific and Syenex Forge Strategic Alliance to Expand Access to High-Quality Plasmid DNA for Advanced Therapies
Syenex's best-in-class delivery platforms. In parallel, Bionova expands its off-the-shelf and custom LVV plasmid system offerings, including gag/pol, rev, VSV-G, and transgene backbones, available from RUO through GMP.This integrated approach enables rapid program initiation with off-the-shelf RUO
More news about: Bionova Scientific
Jan 08, 2026, 09:00 ET CBCC Global Research Rebrands to REV Clinical to Reflect Next Stages of Growth
The name REV reflects Reliability, Excellence, and Velocity. With its new branding, REV Clinical carries forward its deep heritage and expertise in clinical oncology and rare diseases from its founding
More news about: REV Clinical
Jan 08, 2026, 08:37 ET Brave Healer Productions Releases the Third Volume of 100 Poems and Possibilities for Healing
Veneziano Fry, Norman Gordon, Elizabeth R. Kipp, Dylan T. MacDonald, Francesca MacDonald, Melissa T. Maxwell, David D. McLeod, Marquis "13 of Nazareth" Mix, Rev. Dr. Karen Schuder, Sensei Timothy Stuetz, Dinahsta "Miss Kiane" Thomas, Lulu Pearl Trevena, and Angela Valis.As with prior volumes in the series,
More news about: Brave Healer Productions
Jan 07, 2026, 16:44 ET REV Group Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of REV Group, Inc. - REVG
REV Group, Inc. (NYSE: REVG) to Terex Corporation (NYSE: TEX). Under the terms of the proposed transaction, shareholders of REV Group will receive $8.71 in cash plus 0.9809 of a share of the combined company for each share of REV Group that they own. KSF is seeking
More news about: Kahn Swick & Foti, LLC
Jan 07, 2026, 11:55 ET John Hope Bryant to Keynote National 'Martin Luther King, Jr. Celebration' at Georgia State Capitol
John Hope Bryant, will provide Keynote Remarks at the annual Celebration of Service honoring Rev. Dr. Martin Luther King, Jr. on Friday, January 16, 2025, at 10 a.m. at the North Wing Steps of the Georgia State Capitol in Atlanta. The event is hosted
More news about: Operation HOPE, Inc.
Jan 07, 2026, 09:00 ET HitTrax Introduces the HitTrax REV™ Optical, AI-Assisted Pitching Analytics System at ABCA 2026
pitch characteristics by analyzing reflected radio-frequency signals, HitTrax REV directly observes the baseball itself during flight. Using high-speed optical sensors combined with proprietary AI and neural-network algorithms, REV visually detects and tracks the actual seams of the baseball throughout the
More news about: HitTrax
Jan 06, 2026, 11:54 ET Clearlight Energy Announces Leadership Transition
Murff has played a significant role within the LS Power group for over two decades and most recently served as Chief Operating Officer of REV Renewables, another industry leader in the acquisition, development, and operation of clean energy generation and storage within the broader LS Power
More news about: Clearlight Energy
Jan 06, 2026, 11:35 ET Siemens brings the industrial metaverse to life with Digital Twin Composer
Composer establishes a digital thread that connects the silos of design, engineering, and operations across the Siemens Xcelerator ecosystem," said Rev Lebaredian, vice president of Omniverse and Simulation Technology, NVIDIA. "By integrating NVIDIA Omniverse libraries into Digital Twin Composer, enterprises
More news about: Siemens Industry Software
Jan 06, 2026, 11:30 ET Commonwealth Fusion Systems Accelerates Commercial Fusion With Siemens and Nvidia, Leveraging AI-Powered Digital Twins
in the race to commercial fusion.""Delivering commercial fusion demands that we simulate and solve incredibly complex physics problems," said Rev Lebaredian, Vice President, Omniverse and Simulation Technology, NVIDIA. "By using Siemens NX software and NVIDIA Omniverse libraries to create a high-fidelity
More news about: Commonwealth Fusion Systems
Jan 06, 2026, 10:30 ET Episcopal Relief & Development Offers Lenten Meditations by Sister Monica Clare
strengthen a life of faith."To maintain clarity in a world of constant change, we need to attend to our spiritual lives each day," said the Most Rev. Sean W. Rowe, presiding bishop of The Episcopal Church. "Most often, spiritual growth happens not in grand moments, but through modest and consistent
More news about: Episcopal Relief & Development
Jan 06, 2026, 05:57 ET GORE GAINS FDA APPROVAL FOR FIRST DEEP VENOUS STENT INDICATED FOR THE IVC AND ILIOFEMORAL VEINS
insurers.Reference:1. GORE® VIABAHN® FORTEGRA Venous Stent [Instructions for Use] W. L. Gore & Associates, Inc; 2025. MD205743. Rev. 2.For complete indications and other important safety information for Gore commercial products referenced herein, refer to the applicable Instructions
More news about: W. L. Gore & Associates, Inc. MPD Division
Jan 05, 2026, 08:00 ET Novo Nordisk's Wegovy® pill, the first and only oral GLP-1 for weight loss in adults, now broadly available across America
World Obesity Federation. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017;18(7):715–723. Garvey WT, Mechanick JI, Brett EM, et al. American association of clinical endocrinologists and American College of
More news about: NOVO NORDISK INC.
Dec 30, 2025, 11:24 ET 'Undaunted': Book Follows Iconic Life, Inglorious Death of NASA Chaplain and Decorated WW2 Disabled Texas Veteran
Pen-L Publishing in 2018, although the final chapter is still churning in Texas courts.The force behind the quest to land a Bible on the moon was Rev. John M. Stout, a NASA scientist who oversaw parts on the behemoth Saturn V rockets that would take Apollo astronauts to the moon -- and along with them
More news about: Pen-L Publishing
Dec 29, 2025, 08:43 ET Small Church Seeks Return of Apollo Prayer League Assets It Claims Were Confiscated by State of Texas
Rev. John Stout, a former NASA scientist and chaplain to the astronauts, helped form the 40,000-member Apollo Prayer League (APL) made up of NASA employees
More news about: Pen-L Publishing
Dec 23, 2025, 07:00 ET Keeper Security Achieves FedRAMP® High Authorization, Strengthening Protection for High-Impact Federal Systems
individuals. Keeper's authorization confirms that KSGC has been assessed against and meets the FedRAMP High baseline controls defined in NIST SP 800-53 Rev. 5, enabling agencies to strengthen their zero-trust adoption and accelerate secure cloud transformation.KSGC is a unified, cloud-native zero-trust
More news about: Keeper Security
Dec 22, 2025, 18:03 ET FDA approves Novo Nordisk's Wegovy® pill, the first and only oral GLP-1 for weight loss in adults
World Obesity Federation. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev. 2017;18(7):715–723.Garvey WT, Mechanick JI, Brett EM, et al. American association of clinical endocrinologists and American College of Endocrinology
More news about: NOVO NORDISK INC.
Dec 18, 2025, 08:00 ET Novo Nordisk files for FDA approval of CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues for weight management
JPH; World Obesity Federation. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Rev. 2017;18(7):715-723. Garvey WT, Mechanick JI, Brett EM, et al. American association of clinical endocrinologists and American College of Endocrinology
More news about: NOVO NORDISK INC.
Dec 18, 2025, 08:00 ET Novo Nordisk files for FDA approval of CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues for weight management
JPH; World Obesity Federation. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Rev. 2017;18(7):715-723. Garvey WT, Mechanick JI, Brett EM, et al. American association of clinical endocrinologists and American College of Endocrinology
More news about: NOVO NORDISK INC.